会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 20. 发明授权
    • Human myeloid terminal differentiation response gene
    • 人骨髓末端分化反应基因
    • US06913891B1
    • 2005-07-05
    • US09208206
    • 1998-12-09
    • Benjamin Graeme CocksJanice Au-YoungJeffrey J. Seilhamer
    • Benjamin Graeme CocksJanice Au-YoungJeffrey J. Seilhamer
    • A61K38/00A61K48/00C07K14/47C12N15/12C12N15/19G01N33/53
    • C07K14/47A61K38/00A61K48/00
    • The present invention provides polynucleotide and amino acid sequences which encode and identify a novel human myeloid terminal differentiation response gene designated MYD118. The present invention also provides for myd118 antisense molecules. The invention further provides genetically engineered expression vectors and host cells for the production of purified MYD118 polypeptide; antibodies, antagonists and inhibitors of MYD118 polypeptide; and pharmaceutical compositions and methods of treatment based on polynucleotide sequences encoding MYD118 and MYD118 polypeptide. The invention specifically provides for use of the myd118 polynucleotide sequences as a diagnostic composition for the detection of myeloproliferative diseases and leukemias. The invention also relates to therapeutic methods and compositions based upon the nucleotide sequences for myd118. The invention further provides antibodies which specifically bind to MYD118.
    • 本发明提供编码和鉴定指定为MYD118的新型人骨髓末端分化应答基因的多核苷酸和氨基酸序列。 本发明还提供了myd118反义分子。 本发明进一步提供用于产生纯化的MYD118多肽的遗传工程表达载体和宿主细胞; 抗体,拮抗剂和MYD118多肽的抑制剂; 以及基于编码MYD118和MYD118多肽的多核苷酸序列的药物组合物和治疗方法。 本发明特别提供了myd118多核苷酸序列用作检测骨髓增生性疾病和白血病的诊断组合物。 本发明还涉及基于myd118的核苷酸序列的治疗方法和组合物。 本发明进一步提供特异性结合MYD118的抗体。